triptolide has been researched along with Laryngeal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Clotaire, DZ; Han, Y; Huang, W; Lei, M; Luo, H; Ousman, T; Ren, X; Wang, C; Zhang, B; Zhao, F | 1 |
1 other study(ies) available for triptolide and Laryngeal Neoplasms
| Article | Year |
|---|---|
Triptolide induces growth inhibition and apoptosis of human laryngocarcinoma cells by enhancing p53 activities and suppressing E6-mediated p53 degradation.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Diterpenes; Epoxy Compounds; Humans; Laryngeal Neoplasms; Oncogene Proteins, Viral; Phenanthrenes; Tumor Suppressor Protein p53 | 2013 |